Galang, Gilyn S.
HRN: 22-34-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/30/2022
01/01/2023
IVT
500mg
Q 8 Hrs
LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes